Daily Archives: 31/10/2010

Hepatitis C Cont…

In addition to my previous post on Hepatitis C drug development, BMS also updated new biotech development which is a novel Interferon in Development for the Treatment of Hepatitis C (PEG-Interferon Lambda). PEG-Interferon lambda is a novel and potential first-in-class interferon in development … Continue reading

Posted in Drug developments & targets | Leave a comment

Hepatitis C Newer drugs and Combinations

Drug makers including Merck & Co., Johnson & Johnson and Bristol-Myers Squibb Co/Gilead have been racing to come up with new treatments for Hepatitis C. Telaprevir: Telaprevir is co-developed by Vertex and Johnson&Johnson.  Telaprevir shows promising results in Phase 3 studies … Continue reading

Posted in Daily interesting IP news | Tagged , , , , | Leave a comment

India: Cipla’s Oppositions compilation

This is an attempt to collect Cipla’s oppositions (pre/post) from publically available resources Application/Patent No Applicant/Patentee Drugs 329/DELNP/2004 Tibotec Intermediate IN/PCT/2002/00497/DEL OSI Pharma Erlotinib polymorph 1647/DELNP/2000 Tibotec Tenofovir/emtricitabine 3383/DELNP/2005 Gilead Tenofovir combinations 896/DEL/2002 Gilead Tenofovir 2076/DEL/1997 Gilead Tenofovir 3598/DELNP/2004 Tibotec … Continue reading

Posted in Uncategorized | Leave a comment